Marco Arellano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Arellano has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Javier Pizarro-Berdichevsky
Santiago, Chile
2 shared publications - Silvana Gonzalez
Corporación de Innovación en Piso Pélvico Hospital Dr. Sótero del Río Santiago Chile Corporación de Innovación en Piso Pélvico, Hospital Dr. Sótero del Río, Santiago, Chile
2 shared publications Alejandro Pattillo
Urogynecology Unit H. Dr. Sotero del Rio Santiago Chile
1 shared publication- Alejandro Pattillo
Clínica Puerto Varas Puerto Varas Chile Clínica Puerto Varas, Puerto Varas, Chile
1 shared publication - Andrea Maluenda
Centro de innovación en Piso Pélvico Hospital Dr. Sótero del Río Santiago Chile Centro de innovación en Piso Pélvico, Hospital Dr. Sótero del Río, Santiago, Chile
1 shared publication - Ariel Gorodischer
Department of Psychiatry, Universidad de los Andes, Santiago, Chile
1 shared publication
Latest Publications
- Open Access
- 14 March 2024
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
Prevalence of colorectal symptoms and anal incontinence in patients with pelvic organ prolapse attended at an outpatient urogynecology service
Objective: To analyze data of patients with symptomatic pelvic organ prolapse evaluated with PFDI20 and its subscales to report the prevalence of lower gastrointestinal symptoms and anal incontinence in the population of a public hospital and analyze its impact on quality of life. Methods: Cross-sectional study of patients with symptomatic POP. Patients were evaluated […] Abstract Objective: To analyze data of patients with symptomatic pelvic organ prolapse evaluated with PFDI20 and its subscales to report the prevalence of lower gastrointestinal symptoms and anal incontinence in the population of a public hospital and analyze its impact on quality of life. Methods: Cross-sectional study of patients with symptomatic POP. Patients were evaluated […]
- 14 March 2024
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 46
Open AccessPrevalence of colorectal symptoms and anal incontinence in patients with pelvic organ prolapse attended at an outpatient urogynecology service
Objective: To analyze data of patients with symptomatic pelvic organ prolapse evaluated with PFDI20 and its subscales to report the prevalence of lower gastrointestinal symptoms and anal incontinence in the population of a public hospital and analyze its impact on quality of life. Methods: Cross-sectional study of patients with symptomatic POP. Patients were evaluated […] Abstract Objective: To analyze data of patients with symptomatic pelvic organ prolapse evaluated with PFDI20 and its subscales to report the prevalence of lower gastrointestinal symptoms and anal incontinence in the population of a public hospital and analyze its impact on quality of life. Methods: Cross-sectional study of patients with symptomatic POP. Patients were evaluated […]
- 2 May 2016
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 56 (4) , 391-397
Association between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patients
Background: There is no consensus on the relationship between depressive symptoms (DS) and pelvic organ prolapse (POP) symptoms and quality of life (QoL). Our hypothesis was that women with DS and POP have worse symptoms and QoL than those without DS and POP.Aim: Our aim was to compare two groups of POP patients, those with depressive symptoms and those without, and evaluate the association of symptoms and QoL.Materials and methods: This planned report is part of a prospective study evaluating the impact of pessary use among symptomatic POP patients. Patients were evaluated by POP quantification (POP‐Q), pelvic ultrasound (US), voiding diaries, stress test, pad test, Pelvic Floor Distress Inventory (PFDI‐20), Prolapse QoL (P‐QoL) and the Goldberg Health Questionnaire (GHQ‐12) (psychological health screening for DS when score ≥5). A sample size of 78 patients was required to demonstrate a 50‐point difference in the global PFDI‐20 score with 80% power and 95% probability.Results: Ninety‐one women with POP were included. GHQ‐12 was positive in 47 (51.6%) patients. No differences were found in POP‐Q, pad and stress test between those with a positive GHQ‐12 and those without. However, GHQ‐12 was associated with higher PFDI‐20 scores and higher scores in seven of nine P‐QoL domains. GHQ‐12 persisted as an independent risk factor for worse P‐QoL scores after multivariable analysis.Conclusion: A ‘positive’ screening for DS was associated with worse PFDI‐20 and P‐QoL scores despite no difference in objective measurements. It may be that depressed patients interpret their symptoms differently.
- 2 May 2016
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 56 (4) , 391-397
Association between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patients
Background: There is no consensus on the relationship between depressive symptoms (DS) and pelvic organ prolapse (POP) symptoms and quality of life (QoL). Our hypothesis was that women with DS and POP have worse symptoms and QoL than those without DS and POP.Aim: Our aim was to compare two groups of POP patients, those with depressive symptoms and those without, and evaluate the association of symptoms and QoL.Materials and methods: This planned report is part of a prospective study evaluating the impact of pessary use among symptomatic POP patients. Patients were evaluated by POP quantification (POP‐Q), pelvic ultrasound (US), voiding diaries, stress test, pad test, Pelvic Floor Distress Inventory (PFDI‐20), Prolapse QoL (P‐QoL) and the Goldberg Health Questionnaire (GHQ‐12) (psychological health screening for DS when score ≥5). A sample size of 78 patients was required to demonstrate a 50‐point difference in the global PFDI‐20 score with 80% power and 95% probability.Results: Ninety‐one women with POP were included. GHQ‐12 was positive in 47 (51.6%) patients. No differences were found in POP‐Q, pad and stress test between those with a positive GHQ‐12 and those without. However, GHQ‐12 was associated with higher PFDI‐20 scores and higher scores in seven of nine P‐QoL domains. GHQ‐12 persisted as an independent risk factor for worse P‐QoL scores after multivariable analysis.Conclusion: A ‘positive’ screening for DS was associated with worse PFDI‐20 and P‐QoL scores despite no difference in objective measurements. It may be that depressed patients interpret their symptoms differently.